AIMS: To determine the risk perception of Type 2 diabetes in participants in a stepwise population-screening programme. METHODS: This study was carried out within the framework of a stepwise Type 2 diabetes population screening in the general (age 50-75 years) Dutch population. Main outcome measures were perceived risk of having diabetes and perceived seriousness of diabetes, based on a self-report questionnaire, completed before being informed about the diagnosis (Type 2 diabetes yes/no) of the screening procedure. Among 7736 participants, the risk perception of 217 screening-detected participants was compared with 4435 with a low-risk profile for undiagnosed Type 2 diabetes. RESULTS: Of 7736 participants, 43.5% could not give an estimate of their risk of having diabetes, 31.2% estimated their risk to be 0% and 25.3% estimated their risk to be 10% or higher. Compared with 4435 participants with an objectively low risk profile, 217 screening-detected participants were more likely to answer 'I do not know' (52.4% vs. 40.1%, P < 0.001), perceived their risk less often to be 0% (19.3% vs. 34.7%, P < 0.001), and slightly more often perceived their risk to be 10% or higher (28.3% vs. 25.2%, P < 0.001). Overall, more than half of the total population, including both participants with a low risk profile and the screening-detected participants, perceived diabetes as a (very) serious disease. Higher age, obesity and taking anti-hypertensive drugs did not translate into a higher perceived risk. CONCLUSIONS: Among screening-detected participants the seriousness of Type 2 diabetes was generally acknowledged, whilst the perceived risk of having Type 2 diabetes was low, despite the presence of risk factors.
AIMS: To determine the risk perception of Type 2 diabetes in participants in a stepwise population-screening programme. METHODS: This study was carried out within the framework of a stepwise Type 2 diabetes population screening in the general (age 50-75 years) Dutch population. Main outcome measures were perceived risk of having diabetes and perceived seriousness of diabetes, based on a self-report questionnaire, completed before being informed about the diagnosis (Type 2 diabetes yes/no) of the screening procedure. Among 7736 participants, the risk perception of 217 screening-detected participants was compared with 4435 with a low-risk profile for undiagnosed Type 2 diabetes. RESULTS: Of 7736 participants, 43.5% could not give an estimate of their risk of having diabetes, 31.2% estimated their risk to be 0% and 25.3% estimated their risk to be 10% or higher. Compared with 4435 participants with an objectively low risk profile, 217 screening-detected participants were more likely to answer 'I do not know' (52.4% vs. 40.1%, P < 0.001), perceived their risk less often to be 0% (19.3% vs. 34.7%, P < 0.001), and slightly more often perceived their risk to be 10% or higher (28.3% vs. 25.2%, P < 0.001). Overall, more than half of the total population, including both participants with a low risk profile and the screening-detected participants, perceived diabetes as a (very) serious disease. Higher age, obesity and taking anti-hypertensive drugs did not translate into a higher perceived risk. CONCLUSIONS: Among screening-detected participants the seriousness of Type 2 diabetes was generally acknowledged, whilst the perceived risk of having Type 2 diabetes was low, despite the presence of risk factors.
Authors: Marcel C Adriaanse; Jacqueline M Dekker; Annemieke M W Spijkerman; Jos W R Twisk; Giel Nijpels; Henk M van der Ploeg; Robert J Heine; Frank J Snoek Journal: Qual Life Res Date: 2005-08 Impact factor: 4.147
Authors: Corrine I Voils; Cynthia J Coffman; Janet M Grubber; David Edelman; Azita Sadeghpour; Matthew L Maciejewski; Jamiyla Bolton; Alex Cho; Geoffrey S Ginsburg; William S Yancy Journal: J Gen Intern Med Date: 2015-04-16 Impact factor: 5.128
Authors: D Marrero; Q Pan; E Barrett-Connor; M de Groot; P Zhang; C Percy; H Florez; R Ackermann; M Montez; R R Rubin Journal: Qual Life Res Date: 2013-05-26 Impact factor: 4.147
Authors: W Almawi; H Tamim; N Al-Sayed; M R Arekat; G M Al-Khateeb; A Baqer; H Tutanji; C Kamel Journal: J Endocrinol Invest Date: 2008-11 Impact factor: 4.256
Authors: Miranda Pijl; Danielle R M Timmermans; Liesbeth Claassen; A Cecile J W Janssens; Giel Nijpels; Jacqueline M Dekker; Theresa M Marteau; Lidewij Henneman Journal: Diabetes Care Date: 2009-01-08 Impact factor: 17.152
Authors: Corrine I Voils; Cynthia J Coffman; David Edelman; Matthew L Maciejewski; Janet M Grubber; Azita Sadeghpour; Alex Cho; Jamiyla McKenzie; Francoise Blanpain; Maren Scheuner; Margarete Sandelowski; M Patrick Gallagher; Geoffrey S Ginsburg; William S Yancy Journal: Trials Date: 2012-08-01 Impact factor: 2.279
Authors: Andrea L Hernan; Vincent L Versace; Tiina Laatikainen; Erkki Vartiainen; Edward D Janus; James A Dunbar Journal: BMC Public Health Date: 2014-01-30 Impact factor: 3.295